Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal

Chemico-Biological Interactions

Volumn 182, Issue 2-3, 2009, Pages 253-258

  Liu, Jie ^a   Yu, Limei ^a,b   Coppin, Jean Francois ^a   Tokar, Erik J ^a   Diwan, Bhalchandra A ^c   Waalkes, Michael P ^a  

^a National Cancer Institute   (United States)

^b ZUNYI MEDICAL UNIVERSITY   (China)

^c SAIC FREDERICK INC   (United States)

Author keywords

Adrenal; Arsenic; Carcinogenesis; Diethylstilbestrol; Gene expression; Neonatal tissues

Indexed keywords

ALPHA FETOPROTEIN; ANDROSTENEDIONE 15ALPHA HYDROXYLASE; ARSENITE SODIUM; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; DIETHYLSTILBESTROL; DRINKING WATER; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HOMOCYSTEINE; METHIONINE; METHYLTRANSFERASE; OXYGENASE; RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; STEROID; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 5; THIOETHER S METHYLTRANSFERASE; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; FETUS DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; GESTATIONAL AGE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STEROID METABOLISM;

ADRENAL GLANDS; ANIMALS; ARSENIC; CARCINOGENS; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTORS; FEMALE; FETUS; GENE EXPRESSION; MICE; PREGNANCY;

LOTUS; MUS;

EID: 70350236758     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.07.023     Document Type: Article

References (32)

1. NRC (National Research Council). Arsenic in the Drinking Water (Update) (2001), NRC, National Academy, Washington, DC pp. 1-225
2. IARC (International Agency for Research on Cancer), 2004, IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 84: Arsenic in drinking water. In: Some Drinking Water Disinfectants and Contaminants, including Arsenic, IARC, Lyon, France, 2004, pp. 39-267.
3. Waalkes M.P., Ward J.M., Liu J., and Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186 (2003) 7-17
4. Waalkes M.P., Ward J.M., and Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25 (2004) 133-141
5. Waalkes M.P., Liu J., Ward J.M., Powell D.A., and Diwan B.A. Urogenitial system cancers in female CD1 mice induced by in utero arsenic exposure are exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66 (2006) 1337-1445
6. Waalkes M.P., Liu J., Ward J.M., and Diwan B.A. Tumors and proliferative lesions of liver, urinary bladder, adrenal, lung, and kidney in male CD1 mice after transplacental exposure to inorganic arsenic and postnatal treatment with diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215 (2006) 295-305
7. Waalkes M.P., Liu J., Germolec D.R., Trempus C.S., Cannon R.E., Tokar E.J., Tennant R.W., Ward J.M., and Diwan B.A. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 68 (2008) 8278-8285
8. Concha G., Vogler G., Lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44 (1998) 185-190
9. Devesa V., Adair B.M., Liu J., Waalkes M.P., Diwan B.A., Styblo M., and Thomas D.J. Speciation of arsenic in the maternal and fetal mouse tissues following gestational exposure to arsenite. Toxicology 224 (2006) 147-155
10. Anderson L.M., Diwan B.A., Fear N.T., and Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108 Suppl. 3 (2000) 573-594
11. Waalkes M.P., Liu J., Chen H., Xie Y., Achanzar W.E., Zhou Y.S., Cheng M.L., and Diwan B.A. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96 (2004) 466-474
12. Waalkes M.P., Liu J., and Diwan B.A. Transplacental arsenic carcinogenesis in mice. Toxicol. Appl. Pharmacol. 222 (2007) 271-280
13. Hinson J.P., and Raven P.W. Effects of endocrine-disrupting chemicals on adrenal function. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 111-112
14. Liu J., Xie Y., Ward J.M., Diwan B.A., and Waalkes M.P. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol. Sci. 77 (2004) 249-257
15. Liu J., Xie Y., Ducharme D.M.K., Shen J., Diwan B.A., Merrick B.A., Grissom B.A.S.F., Tucker C.J., Paules P.S., Tennant R.M.P., and Waalkes M.P. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ. Health Perspect. 114 (2006) 404-411
16. Liu J., Xie Y., Merrick B.A., Shen J., Ducharme D.M.K., Collins J., Diwan B.A., Logsdon D., and Waalkes M.P. Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures induced similar aberrant gene expressions in male and female mouse liver tumors. Toxicol. Appl. Pharmacol. 213 (2006) 216-223
17. Shen J., Liu J., Xie Y., Diwan B.A., and Waalkes M.P. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol. Sci. 95 (2007) 313-320
18. Liu J., Xie Y., Cooper R., Ducharme D.M.K., Tennant R., Diwan B.A., and Waalkes M.P. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol. Appl. Pharmacol. 220 (2007) 284-291
19. Liu J., Yu L., Tokar E.J., Bortner C., Sifre M.I., Sun Y., and Waalkes M.P. Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures. Ann. N. Y. Acad. Sci. 1140 (2008) 368-375
20. M. Benkhalifa, D. Montjean, P. Cohen-Bacrie, Y. Ménézo, Imprinting: RNA expression for homocysteine recycling in the human oocyte. Fertil. Steril., in press.
21. Wilson C.L., Sims A.H., Howell A., Miller C.J., and Clarke R.B. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr. Relat. Cancer 13 (2006) 617-628
22. Birnbaum L.S., and Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111 (2003) 389-394
23. Steele W., Allegrucci C., Singh R., Lucas E., Priddle H., Denning C., Sinclair K., and Young L. Human embryonic stem cell methyl cycle enzyme expression: modeling epigenetic programming in assisted reproduction?. Reprod. Biomed. 10 (2005) 755-766
24. Pajares M.A., and Pérez-Sala D. Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism?. Cell Mol. Life Sci. 63 23 (2006) 2792-2803
25. Xie Y., Liu J., Benbrahim-Tallaa L., Ward J.M., Logsdon D.D., Diwan B.A., and Waalkes M.P. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 236 (2007) 7-15
26. Fottner Ch., Hoeflich A., Wolf E., and Weber M.M. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm. Metab. Res. 36 (2004) 397-405
27. Coulter C.L. Fetal adrenal development: insight gained from adrenal tumors. Trends Endocrinol. Metab. 16 (2005) 235-242
28. de Fraipont F., El Atifi M., Cherradi N., Le Moigne G., Defaye G., Houlgatte R., Bertherat J., Bertagna X., Plouin P.F., Baudin E., Berger F., Gicquel C., Chabre O., and Feige J.J. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab. 90 (2005) 1819-1829
29. Cook J.D., Davis B.J., Cai S.L., Barrett J.C., Conti C.J., and Walker C.L. Interaction between genetic susceptibility and early life environmental exposure determines tumor suppressor gene penetrance. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8644-8649
30. Smith A.H., Marshall G., Yuan Y., Ferreccio C., Liaw J., von Ehrenstein O., Steinmaus C., Bates M.N., and Selvin S. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114 (2006) 1293-1296
31. Liaw J., Marshall G., Yuan Y., Ferreccio C., Steinmaus C., and Smith A.H. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 1982-1987
32. Kitchin K.T., and Wallace K. Arsenic binding to synthetic peptides based on the Zn finger region and the estrogen binding region of human estrogen receptor-alpha. Toxicol. Appl. Pharmacol. 206 (2005) 66-72